Cargando…
Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
BACKGROUND: Recommendations for secondary hyperparathyroidism (SHPT) consider that a “one-size-fits-all” target enables efficacy of care. In routine clinical practice, SHPT continues to pose diagnosis and treatment challenges. One hypothesis that could explain these difficulties is that dialysis pop...
Autores principales: | Laurain, Emmanuelle, Ayav, Carole, Erpelding, Marie-Line, Kessler, Michèle, Briançon, Serge, Brunaud, Laurent, Frimat, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236624/ https://www.ncbi.nlm.nih.gov/pubmed/25123022 http://dx.doi.org/10.1186/1471-2369-15-132 |
Ejemplares similares
-
Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study
por: Filipozzi, Pierre, et al.
Publicado: (2017) -
Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
por: Ayav, Carole, et al.
Publicado: (2016) -
Radioimmunoassay of Parathyroid Hormone in Primary Hyperparathyroidism
por: Buckle, R. M.
Publicado: (1968) -
Predialysis therapeutic care and health-related quality of life at dialysis onset (The pharmacoepidemiologic AVENIR study)
por: Boini, Stephanie, et al.
Publicado: (2011) -
Parathyroid Hormone on Osteoprotegerin Levels in Patients with Primary Hyperparathyroidism
por: Okudan, Berna, et al.
Publicado: (2022)